Aegis
Aegis
  • Home
  • The Aegis Platform
  • For Clinics
  • Investors
  • Team
  • Regulatory Disclosures
  • More
    • Home
    • The Aegis Platform
    • For Clinics
    • Investors
    • Team
    • Regulatory Disclosures
  • Sign In
  • Create Account

  • My Account
  • Signed in as:

  • filler@godaddy.com


  • My Account
  • Sign out

Signed in as:

filler@godaddy.com

  • Home
  • The Aegis Platform
  • For Clinics
  • Investors
  • Team
  • Regulatory Disclosures

Account

  • My Account
  • Sign out

  • Sign In
  • My Account

Investor Hub

Digital shield logo representing Ascend Aegis with performance and efficiency stats.

Investment Thesis: The 10X Transformation

Ascend Aegis has retired technical risk (94% accuracy) and mitigated market risk (MedSleep partnership). With infrastructure costs deferred through our Nuvollo partnership, this pre-seed round is a pure deployment and regulatory sprint to own the sleep diagnostic market.

The Problem: The Diagnostic Bottleneck

In modern sleep medicine, data collection has outpaced human analysis. Millions of hours of PSG data are generated annually, but the industry remains tethered to manual scoring.


  • Slow & Expensive: Manual scoring takes hours and costs hundreds per study.
  • Inconsistent: High variability between human scorers leads to diagnostic lag.
  • The Scaling Gap: When your only path to expansion is adding more human labour, your backlog grows faster than your business.

The Aegis Advantage: Precision, Profit, and Proven Path

The Breakthrough: 94% Staging Accuracy

We have solved the "Holy Grail" of automated sleep diagnostics.

The Technical Milestone

The Technical Milestone

The Technical Milestone

Achieved 94% average staging accuracy (Wake-N1-N2-N3-REM) using our proprietary Transformer-based architecture.

The Commercial Proof

The Technical Milestone

The Technical Milestone

Validated by MedSleep Inc. (Canada’s largest network) with a $25k MVP payment and an MOU for 40,000 annual studies.

Visual Insights:

Clinical Validation: Side-by-side hypnogram comparison showing the near-identical alignment between manual human scoring (MedSleep) and Aegis AI automated staging.


Acquisition #02602506-110978

The Unfair Advantage: Capital Efficiency

100% Capital Velocity. While other AI startups burn seed funding on server costs, Aegis is subsidized for growth.


The Nuvollo Partnership Through a strategic alliance with Nuvollo, Aegis has secured a private, high-performance cloud environment on a deferred payment schedule for a full year (starting Jan 1, 2026).
Impact: Your investment goes directly into commercialization, regulatory filings, and clinic acquisitions, not infrastructure bills.

The Roadmap: Commercializing & The GTA Blitz

Our pre-seed capital is weaponized for three specific, high-value milestones:

  • Production Hardening: Moving from a validated model to a secure, EMR-integrated platform clinics trust every morning.
  • Regulatory Sprint: Finalizing the Health Canada MDEL and FDA 510(k) applications.
  • The GTA Blitz: A concentrated acquisition strategy across the Greater Toronto Area to achieve regional dominance before national expansion.

The Strategic Advantage: Clinical Precision Meets Operational Scale

  • Technical De-Risking: Ascend Aegis is built on the intersection of medical-grade research and national-scale infrastructure. This duo ensures we don't just build a model, we build a licensed medical device.


Executive Summary: Why This Pair? The path to FDA and Health Canada licensing for a sleep diagnostic tool typically fails at one of two hurdles: Clinical Inaccuracy or Production Fragility.

  • Frank Tabuco solves the first by delivering models that reach and defend clinical-grade accuracy.
  • Lester Lagrimas solves the second by turning those models into secure, national-scale production services.
  • Together, they reduce technical risk and accelerate the time-to-proof required for market entry.


The Matrix of Expertise:

Frank Tabuco: The Accuracy Engine

  • Implements sequence models (LSTM/GRU/Transformers) for 80-90%+ accuracy.
  • Validates models against "noisy" clinical data and inter-rater variability.
  • Optimizes model graphs for high-speed inference on varied hardware.
  • Designs multi-task heads to cover apneas, hypopneas, and desaturations simultaneously.


Lester Lagrimas: The Production Backbone

  • Ensures data pipelines (EDF to RML) are reproducible and auditable for examiners.
  • Builds PHIPA/HIPAA-compliant plumbing with strict logging and encryption.
  • Integrates outputs directly into EMR systems using HL7/FHIR standards.
  • Manages hybrid cloud/on-prem deployments to keep COGS low.


Proven Execution Within Aegis

This is not a theoretical partnership; the duo is already executing on the following core infrastructure:

  • Standardized Data Flows: Mature flows moving from raw EDF files to RML labels and Parquet features are already in place.
  • Production Guardrails: Strict AASM v3 alignment and audit trails are embedded as system guardrails, not afterthoughts.
  • Architecture for Growth: The platform is designed to scale beyond sleep into cardiology, respiratory, and neurology.


The "Moat": Defensibility Through Peer Review

Unlike many startups, the Aegis engineering team leads with defensible, community-visible science. By pairing a Medical-AI Specialist with a Systems Architect, Ascend Aegis eliminates the "Research-to-Production" gap that plagues most healthcare startups. This duo ensures the Aegis Sleep Diagnostic Tool is built to be licensed, built to be trusted, and built to scale..  

  • Frank’s history of peer-reviewed work (e.g., 95%+ Dice in echocardiography) provides the transparency required for Medical Director sign-off.
  • Lester’s background in national-scale sensor fusion and early-warning systems provides the "battle-tested" reliability that wins over purchasing committees.


Video

$300K De-risking Funding

Ascend Aegis is an AI-driven medical company transitioning from a software tool to a comprehensive healthcare operating system. The "Deconstructing the Pitch" video outlines their strategy to build a market monopoly through three core pillars:

  • Regulatory Sovereignty: Securing FDA and Health Canada clearances to establish their product as the industry standard and create high barriers to entry.
  • Clinical Integrity: Proving the AI's effectiveness across diverse hardware and biological data through multi-center studies.
  • Commercial Proof: Demonstrating a high-margin, scalable business model that untethers healthcare from human labour.


Seed A Capital Deployment

Ascend Aegis is revolutionizing the healthcare landscape by developing a comprehensive diagnostic operating system. This video explores the company's strategic vision to:

  • Industrialize Clinical Work: Automate the labor-intensive process of sleep study scoring, reducing analysis time from hours to under five minutes with 95%+ accuracy.
  • Scale Efficiently: Decouple revenue from manual labour through a high-margin SaaS model, allowing clinics to grow exponentially via the cloud.
  • Expand Beyond Sleep: Utilize a "wedge" strategy starting with sleep diagnostics before applying their signal-agnostic AI to other medical fields like cardiology and pulmonology.

Ascend Aegis Corporation

95 Mural Street, Richmond Hill, Ontario, Canada L4B 3G2

Copyright © 2026 Ascend Aegis Corporation. All Rights Reserved.

Powered by Nuvollo Cloud

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept